Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -47.94 Million AUD | -38.54% |
| 2023 | -34.61 Million AUD | -14.08% |
| 2022 | -30.33 Million AUD | -6153.01% |
| 2021 | -485.19 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -47.94 Million AUD | -38.54% |
| 2024 Q4 | -23.19 Million AUD | -100.0% |
| 2024 Q2 | -24.75 Million AUD | -100.0% |
| 2024 Q1 | -12.37 Million AUD | 43.88% |
| 2024 Q3 | -11.59 Million AUD | 53.17% |
| 2023 FY | -34.61 Million AUD | -14.08% |
| 2023 Q3 | -11.02 Million AUD | 12.13% |
| 2023 Q1 | -6.27 Million AUD | 51.83% |
| 2023 Q4 | -22.05 Million AUD | -100.0% |
| 2023 Q2 | -12.55 Million AUD | -100.0% |
| 2022 Q4 | -13.02 Million AUD | -100.0% |
| 2022 FY | -30.33 Million AUD | -6153.01% |
| 2022 Q3 | -6.51 Million AUD | 62.54% |
| 2022 Q2 | -17.39 Million AUD | -100.0% |
| 2022 Q1 | -8.69 Million AUD | 0.0% |
| 2021 FY | -485.19 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 788.48% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -3204.006% |
| Zelira Therapeutics Limited | -36.56 Million AUD | -31.12% |
| Biome Australia Limited | -1.67 Million AUD | -2770.857% |
| Patrys Limited | -3.53 Million AUD | -1254.82% |
| Orthocell Limited | -7.18 Million AUD | -567.726% |
| Imugene Limited | -149.68 Million AUD | 67.966% |
| Noxopharm Limited | -3.57 Million AUD | -1240.066% |
| PYC Therapeutics Limited | -37.72 Million AUD | -27.1% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -282.679% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -482.045% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -651.999% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -392.053% |
| CSL Limited | 2.64 Billion AUD | 101.815% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -448.238% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -1890.268% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 234.551% |
| Starpharma Holdings Limited | -8.16 Million AUD | -487.252% |
| Nanollose Limited | -1.15 Million AUD | -4045.864% |
| Memphasys Limited | -4.44 Million AUD | -979.444% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -2820.505% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 14889.525% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -964.719% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -245.711% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -1574.015% |
| Race Oncology Limited | -13.81 Million AUD | -246.971% |
| Nyrada Inc. | -1.38 Million AUD | -3358.966% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 1020.152% |
| Dimerix Limited | -17.07 Million AUD | -180.813% |
| PharmAust Limited | -9.03 Million AUD | -430.859% |
| Immutep Limited | -39.89 Million AUD | -20.184% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | -13.289% |
| Alterity Therapeutics Limited | -19.12 Million AUD | -150.734% |
| BTC Health Limited | 1.05 Million AUD | 4643.704% |
| Acrux Limited | -5.8 Million AUD | -726.709% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 130.525% |
| Biotron Limited | -3.43 Million AUD | -1295.28% |
| Tissue Repair Ltd | -4.13 Million AUD | -1058.722% |
| AdAlta Limited | -5.38 Million AUD | -791.037% |
| Hexima Limited | -933.87 Thousand AUD | -5034.437% |
| AnteoTech Limited | -8.88 Million AUD | -439.936% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 18.25% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | -171.486% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -1295.265% |
| Actinogen Medical Limited | -13.04 Million AUD | -267.587% |
| Immuron Limited | -6.93 Million AUD | -591.213% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -775.066% |